MIH
CVS icon

Meitav Investment House’s CVS Health CVS Stock Holding History

Meitav Investment House’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,211
Closed -$332K – 246
2023
Q4 		$332K Buy
4,211
+554
+15% +$39.4K ﹤0.01% 285
2023
Q3 		$257K Sell
3,657
-380
-9% -$26.9K ﹤0.01% 303
2023
Q2 		$277K Sell
4,037
-1,760
-30% -$125K ﹤0.01% 325
2023
Q1 		$430K Sell
5,797
-3,276
-36% -$275K 0.01% 293
2022
Q4 		$844K Sell
9,073
-253
-3% -$24.4K 0.01% 257
2022
Q3 		$910K Buy
9,326
+943
+11% +$93.3K 0.02% 241
2022
Q2 		$781K Hold
8,383
– – 0.01% 251
2022
Q1 		$861K Hold
8,383
– – 0.01% 277
2021
Q4 		$868K Hold
8,383
– – 0.01% 272
2021
Q3 		$722K Hold
8,383
– – 0.01% 274
2021
Q2 		$700K Sell
8,383
-3,655
-30% -$299K 0.02% 279
2021
Q1 		$909 Buy
12,038
+8,055
+202% +$587K 0.03% 219
2020
Q4 		$271K Sell
3,983
-1,959
-33% -$127K 0.01% 352
2020
Q3 		$344K Buy
+5,942
New +$370K 0.02% 307
2020
Q1 		– Sell
-15,970
Closed -$1.19M – 394
2019
Q4 		$1.19M Sell
15,970
-2,961
-16% -$208K 0.09% 149
2019
Q3 		$1.19M Sell
18,931
-6,950
-27% -$412K 0.09% 138
2019
Q2 		$1.42M Buy
25,881
+12,681
+96% +$683K 0.09% 125
2019
Q1 		$705K Buy
13,200
+8,348
+172% +$515K 0.04% 202
2018
Q4 		$318K Buy
+4,852
New +$362K 0.02% 249
2018
Q3 		– Sell
-2,247
Closed -$205K – 445
2018
Q2 		$205K Sell
2,247
-4,054
-64% -$267K 0.01% 404
2018
Q1 		$393K Sell
6,301
-15,852
-72% -$1.14M 0.02% 270
2017
Q4 		$1.62M Buy
+22,153
New +$1.61M 0.09% 103

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Meitav Investment House's CVS Position: Q1 2024 in Review

Meitav Investment House sold out of CVS Health (CVS) in Q1 2024, closing a stake of 4,211 shares — an estimated $332K sold.

Meitav Investment House first reported a position in CVS in Q4 2017 and held it in 22 quarters. The position peaked at $1.62M in Q4 2017. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Meitav Investment House reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Meitav Investment House sold 4,211 CVS Health shares in Q1 2024, an estimated $332K.
  • Meitav Investment House first reported a position in CVS Health in Q4 2017 and held it in 22 quarters.
  • Meitav Investment House's CVS Health position peaked at $1.62M in Q4 2017.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Meitav Investment House's 13F filing for Q1 2024, filed 1 May 2024.